A Fred Hutchinson Cancer Research Center researcher was honored at the annual 2018 Society for Immunotherapy of Cancer (SITC) in Washington DC for work on immune-based treatments for leukemia, ovarian cancer and skin cancer, reports Susan Keown from Fred Hutch News Service.
Dr. Phil Greenberg, who leads Hutch’s program in immunology, was awarded SITC’s highest honor, the Richard V. Smalley, M.D., Memorial Award and Lecturship—the first Fred Hutch researcher to receive the price. For decades, Dr. Greenberg has led foundational discoveries about how immune cells called T cells could target cancer and other diseases. He continues to pioneer innovative T-cell therapies against leukemia and solid tumors like pancreatic and ovarian cancers, and he is recognized worldwide for leadership in his field. Follow the link to read the remainder of Ms. Keown’s article.